Correlation Between MediciNova and Lantern Pharma
Can any of the company-specific risk be diversified away by investing in both MediciNova and Lantern Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Lantern Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MediciNova and Lantern Pharma, you can compare the effects of market volatilities on MediciNova and Lantern Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Lantern Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Lantern Pharma.
Diversification Opportunities for MediciNova and Lantern Pharma
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between MediciNova and Lantern is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Lantern Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lantern Pharma and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Lantern Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lantern Pharma has no effect on the direction of MediciNova i.e., MediciNova and Lantern Pharma go up and down completely randomly.
Pair Corralation between MediciNova and Lantern Pharma
Given the investment horizon of 90 days MediciNova is expected to generate 2.32 times more return on investment than Lantern Pharma. However, MediciNova is 2.32 times more volatile than Lantern Pharma. It trades about 0.13 of its potential returns per unit of risk. Lantern Pharma is currently generating about -0.13 per unit of risk. If you would invest 163.00 in MediciNova on August 29, 2024 and sell it today you would earn a total of 41.00 from holding MediciNova or generate 25.15% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
MediciNova vs. Lantern Pharma
Performance |
| Timeline |
| MediciNova |
| Lantern Pharma |
MediciNova and Lantern Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MediciNova and Lantern Pharma
The main advantage of trading using opposite MediciNova and Lantern Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Lantern Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lantern Pharma will offset losses from the drop in Lantern Pharma's long position.| MediciNova vs. Bright Minds Biosciences | MediciNova vs. HP Inc | MediciNova vs. Intel | MediciNova vs. Chevron Corp |
| Lantern Pharma vs. Bright Minds Biosciences | Lantern Pharma vs. HP Inc | Lantern Pharma vs. Intel | Lantern Pharma vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |